Chronic Activation of the G Protein-Coupled Receptor 30 with Agonist G-1 Attenuates Heart Failure

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Kang, Shoulei ^a   Liu, Ying ^a   Sun, Di ^a   Zhou, Chunle ^a   Liu, Aiying ^a   Xu, Chuanying ^a   Hao, Yanling ^a   Li, Dongye ^a   Yan, Changdong ^a   Sun, Hong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CHEMOKINE RECEPTOR AGONIST; ESTROGEN; G PROTEIN COUPLED RECEPTOR 30; G PROTEIN COUPLED RECEPTOR 30 AGONIST G 1; G PROTEIN COUPLED RECEPTOR 30 AGONIST G 15; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ESTROGEN BLOOD LEVEL; FEMALE; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CYCLOPENTANES; ESTROGENS; FEMALE; HEART FAILURE; ISOPROTERENOL; NATRIURETIC PEPTIDE, BRAIN; OVARIECTOMY; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

RATTUS;

EID: 84868088791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048185     Document Type: Article

References (33)

1. Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, et al. (2004) Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci. 25: 358-365.
2. Zhang GX, Kimura S, Nishiyama A, Shokoji T, Rahman M, et al. (2005) Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res. 65: 230-238.
3. Hamdani N, de Waard M, Messer AE, et al. (2008) Myofilament dysfunction in cardiac disease from mice to men. J Muscle Res Cell Motil. 29: 189-201.
4. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, et al. (1986) Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 59: 297-309.
5. Shizukuda Y, Buttrick PM, (2002) Subtype specific roles of beta-adrenergic receptors in apoptosis of adult rat ventricular myocytes. J Mol Cell Cardiol. 34: 823-831.
6. Brouri F, Hanoun N, Mediani O, Saurini F, Hamon M, et al. (2004) Blockade of beta 1- and desensitization of beta 2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis. Eur J Pharmacol. 485: 227-234.
7. Wu Q, Zhao Z, Sun H, Hao YL, Yan CD, et al. (2008) Oestrogen changed cardiomyocyte contraction and beta-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion. Exp Physiol. 93: 1034-1043.
8. Dong H, Chen Q, Sun S, Yu H, Zhang Z, (2010) Overexpression of beta(2)AR improves contractile function and cellular survival in rabbit cardiomyocytes under chronic hypoxia. Biochem Biophys Res Commun. 398: 383-388.
9. Sun J, Fu L, Tang X, Han Y, Ma D, et al. (2011) Testosterone modulation of cardiac β-adrenergic signals in a rat model of heart failure. Gen Comp Endocrinol. 172: 518-525.
10. Murphy E, Steenbergen C, (2007) Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res. 75: 478-486.
11. Revankar CM, Mitchell HD, Field AS, et al. (2007) Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem Biol. 2: 536-544.
12. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, et al. (2008) Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol. 70: 165-190.
13. Deschamps AM, Murphy E, (2009) Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol. 297: H1806-H1813.
14. Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, et al. (2010) Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery. 148: 436-443.
15. Bopassa JC, Eghbali M, Toro L, Stefani E, (2010) A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 298: H16-H23.
16. Patel VH, Chen J, Ramanjaneya M, Karteris E, Zachariades E, et al. (2010) G-protein coupled estrogen receptor 1 expression in rat and human heart: Protective role during ischaemic stress. Int J Mol Med. 26: 193-199.
17. Haas E, Bhattacharya I, Brailoiu E, et al. (2009) Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res. 104: 288-291.
18. Jessup JA, Lindsey SH, Wang H, Chappell MC, Groban L, (2010) Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats. PLoS One. 5: e15433.
19. Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M (2011) Terminalia arjuna Enhances Baroreflex Sensitivity and Myocardial Function in Isoproterenol-Induced Chronic Heart Failure Rats. J Cardiovasc Pharmacol Ther. [Epub ahead of print] DOI: 10.1177/1074248411416816.
20. Dennis MK, Burai R, Ramesh C, et al. (2009) In vivo effects of a GPR30 antagonist. Nat Chem Biol. 5: 421-427.
21. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC, (2009) Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology. 150: 3753-3758.
22. Hao Y, Sun Y, Xu C, Jiang X, Sun H, et al. (2009) Improvement of contractile function in isolated cardiomyocytes from ischemia-reperfusion rats by ginkgolide B pretreatment. J Cardiovasc Pharmacol. 54: 3-9.
23. Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, et al. (2008) G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology. 149: 4846-4856.
24. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, et al. (2007) Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology. 148: 3236-3245.
25. O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, et al. (1998) Discovery of three novel G-protein-coupled receptor genes. Genomics. 47: 310-313.
26. Roth DM, Gao MH, Lai NC, Drumm J, Dalton N, et al. (1999) Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circulation. 99: 3099-3102.
27. Zhu W, Zeng X, Zheng M, Xiao RP, (2005) The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circ Res. 97: 507-509.
28. Penna C, Abbadessa G, Mancardi D, Tullio F, Piccione F, et al. (2008) Synergistic effects against post-ischemic cardiac dysfunction by sub-chronic nandrolone pretreatment and postconditioning: role of beta2-adrenoceptor. J Physiol Pharmacol. 59: 645-659.
29. Viguerie N, Millet L, Avizou S, Vidal H, Larrouy D, et al. (2002) Regulation of human adipocyte gene expression by thyroid hormone. J Clin Endocrinol Metab. 87: 630-634.
30. Dinçer UD, Bidasee KR, Güner S, Tay A, Ozçelikay AT, et al. (2001) The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts. Diabetes. 50: 455-461.
31. Xu C, Liu A, Sun H, Sun Y, Wang G, et al. (2010) beta2-Adrenoceptor confers cardioprotection against hypoxia in isolated ventricular myocytes and the effects depend on estrogenic environment. J Recept Signal Transduct Res. 30: 255-261.
32. Liu AY, Gao LP, Kang SL, Liu Y, Xu CY, et al. (2011) Testosterone enhances estradiol's cardioprotection in ovariectomized rats. J Endocrinol. 212: 61-69.
33. Guan Y, Gao L, Ma HJ, Li Q, Zhang H, et al. (2010) Chronic intermittent hypobaric hypoxia decreases beta-adrenoceptor activity in right ventricular papillary muscle. Am J Physiol Heart Circ Physiol. 298: H1267-H1272.